United States · Wires & real time · GlobeNewswire
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
Read the full article on GlobeNewswire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

